NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
65 hedge funds and large institutions have $54.7M invested in Niagen Bioscience, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
22
Reduced
11
Closed
11
Calls
$114K
Puts
$48K
Net Calls
+$66K
Net Calls Change
+$77K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$866K |
2 |
BlackRock
New York
|
+$656K |
3 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$540K |
4 |
State Street
Boston,
Massachusetts
|
+$352K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$283K |